Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Tihamer ORBAN; Brian BUNDY; Antoinette MORAN; Mark PEAKMAN; Philip RASKIN; William E RUSSELL; Desmond SCHATZ; Diane K WHERRETT; Darrell M WILSON; Jeffrey P KRISCHER; Jay S SKYLER; Dorothy J BECKER; Linda A DIMEGLIO; Stephen E GITELMAN; Robin GOLAND; Peter A GOTTLIEB; Carla J GREENBAUM; Jennifer B MARKS; Roshanak MONZAVI

doi:10.2337/dc13-0604

Back

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Journal article

Open access

Peer reviewed

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Tihamer ORBAN, Brian BUNDY, Antoinette MORAN, Mark PEAKMAN, Philip RASKIN, William E RUSSELL, Desmond SCHATZ, Diane K WHERRETT, Darrell M WILSON, Jeffrey P KRISCHER, …

Diabetes care, Vol.37(4), pp.1069-1075

2014

DOI: https://doi.org/10.2337/dc13-0604

PMCID: PMC3964491

PMID: 24296850

Abstract

Diabetes. Impaired glucose tolerance

Biological and medical sciences

Endocrinopathies

Etiopathogenesis. Screening. Investigations. Target tissue resistance

Metabolic diseases

Medical sciences

Endocrine pancreas. Apud cells (diseases)

Files and links (1)

url

https://doi.org/10.2337/dc13-0604View

Published (Version of record) Open

Metrics

17 Record Views

135 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.26 Diabetes; 1.26.1016 Type 1 Diabetes
Web Of Science research areas: Endocrinology & Metabolism
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
Creators: Tihamer ORBAN - Joslin Diabetes Center, Boston, MA, United States
Brian BUNDY - University of South Florida, Tampa, FL, United States
Antoinette MORAN - University of Minnesota, Minneapolis, MN, United States
Mark PEAKMAN - King's College London, London, United Kingdom
Philip RASKIN - University of Texas Southwestern Medical School, Dallas, TX, United States
William E RUSSELL - Vanderbilt University, Nashville, TN, United States
Desmond SCHATZ - University of Florida, Gainesville, FL, United States
Diane K WHERRETT - Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Darrell M WILSON - Stanford University, Stanford, CA, United States
Jeffrey P KRISCHER - University of South Florida, Tampa, FL, United States
Jay S SKYLER - University of Miami Diabetes Research Institute, Miami, FL, United States
Dorothy J BECKER - University of Pittsburgh, Pittsburgh, PA, United States
Linda A DIMEGLIO - Indiana University School of Medicine, Indianapolis, IN, United States
Stephen E GITELMAN - University of California, San Francisco, San Francisco, CA, United States
Robin GOLAND - Columbia University, New York, NY, United States
Peter A GOTTLIEB - University of Colorado Barbara Davis Center for Childhood Diabetes, Aurora, CO, United States
Carla J GREENBAUM - Benaroya Research Institute, Seattle, WA, United States
Jennifer B MARKS - University of Miami Diabetes Research Institute, Miami, FL, United States
Roshanak MONZAVI - Children's Hospital Los Angeles, Los Angeles, CA, United States
Publication Details: Diabetes care, Vol.37(4), pp.1069-1075
Publisher: American Diabetes Association; Alexandria, VA
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI)
Language: English
Resource Type: Journal article
PMID: 24296850
PMCID: PMC3964491
Record Identifier: 991031560002302976